posted on 2025-05-05, 09:00authored byIbrahim M. Abukhiran, Amr H. Masaadeh, James D. Byrne, Dustin E. Bosch
Figure S1
History
ARTICLE ABSTRACT
Posttreatment markers of the complete response of rectal carcinoma to neoadjuvant chemoradiation are needed to guide decisions about surgical resection. We found that mucosal microbiome β diversity, bacterial metabolic capacities, and specific taxonomic groups distinguished between complete and incomplete responders. The mucosal microbiome provides markers for complete pathologic response.